RECRUITING

Genetic Testing Decision Aid

Description

This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer

Conditions

Epithelial Ovarian CarcinomaPancreas Adenocarcinoma
Talk to us

Related Conditions:

Epithelial Ovarian CarcinomaPancreas Adenocarcinoma

Study Overview

On this page

Study Details

Study overview

This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer

Randomized, Controlled Trial of an Electronic Decision Aid for Genetic Testing in Inherited Cancer Syndromes

Genetic Testing Decision Aid

Condition
Epithelial Ovarian Carcinoma
Intervention / Treatment

-

Contacts and Locations

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02115

Danvers

Mass General at North Shore Cancer Center, Danvers, Massachusetts, United States, 01923

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years or older
  • * Being seen in clinic at Massachusetts General Hospital or Boston Medical Center
  • * Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma.
  • * Unable or unwilling to provide informed consent, undergo randomization, or complete the surveys associated with the study
  • * Previous germline genetic testing
  • * History of hereditary pancreatitis
  • * Members of the following vulnerable populations: adults unable to consent, individuals who are not yet adults

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Massachusetts General Hospital,

Daniel C. Chung, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

2025-10-31